Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nerviano Medical Sciences

http://www.nervianoms.com/

Latest From Nerviano Medical Sciences

Synnovation Aims At Precision Oncology With $102m In Venture Backing

Third Rock Ventures is leading a $102m series A for Synnovation, a cancer-focused biotech led by several former Incyte scientists. The new firm wants to develop best-in-class drugs against validated targets.

Financing Business Strategies

Deal Watch: Ikena Cuts Staff After BMS Exits IO Partnership

Plus deals involving Lipocine/Verity, Vivtex/AI Proteins, Windtree/Lee’s Pharmaceutical, Biogen/Ji Xing, Sermonix/Henlius and news from the world of technology transfer.

Deal Watch Business Strategies

Deal Watch: Lilly Sends European Commercial Rights For Two Migraine Drugs To Organon

Plus deals involving Biocytogen, Neurocrine and Ona, Aeterna Zentaris/Ceapro, Teva/Biolojic Design, Pathos AI/Rain Oncology, Inhibitor Therapeutics/Johns Hopkins and more.

Deal Watch Business Strategies

Merck KGaA Expects Modest Growth Ahead Of Launches Next Year

The German firm is eyeing licensing opportunities in 2023 to fill up its mid-stage pipeline.

Sales & Earnings Business Strategies
See All

Company Information

  • Other Names / Subsidiaries
    • NerPharMa
UsernamePublicRestriction

Register